Implantable and long-lasting drug delivery systems for cancer treatment
Long-Acting Drug Delivery Systems, Page: 129-162
2022
- 4Citations
- 14Captures
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Book Chapter Description
Cancer represents a huge global health issue and socioeconomic burden. Despite the development of novel therapies, the current cancer treatment is still limited mainly due to systemic toxicity, drug resistance, or pharmacokinetic issues. Therefore alternative delivery systems are needed to improve the efficacy of tumor-targeted drugs. Implantable and long-lasting drug delivery systems (DDS) emerge as a novel and promising therapeutic approach to address these problems. Through local administration and sustained release, they efficiently deliver high drug payloads in the tumor sites, improving drug bioavailability and avoiding healthy tissue damage. Moreover, owing to their unique properties, implant drug release might be closely adjusted over time, creating patient-friendly and versatile platforms. Herein, we intend to address the main features that make implantable DDS suitable for cancer treatment and highlight chemotherapy, hyperthermia, photodynamic therapy, gene therapy, and immunotherapy innovative strategies, based on implantable platforms.
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/B9780128217498000112; http://dx.doi.org/10.1016/b978-0-12-821749-8.00011-2; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85127656812&origin=inward; https://linkinghub.elsevier.com/retrieve/pii/B9780128217498000112; https://dx.doi.org/10.1016/b978-0-12-821749-8.00011-2
Elsevier BV
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know